Endothelium-dependent responses in human isolated thyroid arteries from donors

Journal of Endocrinology

Volumn 181, Issue 3, 2004, Pages 379-384

  Torondel, Belén ^a   Vila, José M ^a   Segarra, Gloria ^b   Lluch, Paloma ^a   Medina, Pascual ^a   Martínez León, Juan ^a   Ortega, Joaquin ^a   Llunch, Salvador ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); APAMIN; BARIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; OUABAIN; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROSTACYCLIN;

ADULT; ARTERY COMPLIANCE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DONOR; FEMALE; HUMAN; HUMAN TISSUE; INHIBITION KINETICS; ISOLATED ARTERY; MALE; PRIORITY JOURNAL; THYROID GLAND;

ACETYLCHOLINE; ADULT; APAMIN; ARTERIES; BIOLOGICAL FACTORS; CHARYBDOTOXIN; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; THYROID GLAND; VASOCONSTRICTION;

EID: 3042844150     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1810379     Document Type: Article

References (40)

1. Angus JA, Cocks TM & Satoh K 1986 The alpha adrenoceptors on endothelial cells. FASEB Journal 45 2355-2359.
2. Campbell WB, Gebremedhin D, Pratt PF & Harder DR 1996 Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circulation Research 78 415-423.
3. Chauhan SD, Nilsson H, Ahluwalia A & Hobbs AJ 2003 Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. PNAS 100 1426-1431.
4. Coats P, Johnston F, MacDonald J, McMurray JJV & Hillier C 2001 Endothelium-derived hyperpolarizing factor. Identification and mechanisms of action in human subcutaneous resistance arteries. Circulation 103 1702-1708.
5. Cohen RA & Vanhoutte PM 1995 Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 92 3337-3349.
6. Colin IM, Kopp P, Zbaren J, Haberli A, Grizzle WE & Jameson JL 1997 Expression of nitric oxide synthase III in human thyroid follicular cells: evidence for increased expression in hyperthyroidism. European Journal of Endocrinology 136 649-655.
7. Dora KA, Doyle MP & Duling BR 1997 Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. PNAS 94 6529-6534.
8. Dora KA, Hinton JM, Walker SD & Garland CJ 2000 An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. British Journal of Pharmacology 129 381-387.
9. Doughty JM, Plane F & Langton PD 1999 Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. American Journal of Physiology 276 H1107-H1112.
10. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396 269-272.
11. Feletou M & Vanhoutte PM 1988 Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British Journal of Pharmacology 93 515-524.
12. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I & Busse R 1999 Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 493-497.
13. Hermenegildo C, Medina P, Peiró M, Segarra G, Vila JM, Ortega J & Lluch S 2002 Plasma concentrations of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients. Journal of Clinical Endocrinology and Metabolism 87 5636-5640.
14. Jones CJ, DeFily DV, Patterson JL & Chilian WM 1993 Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 87 1264-1274.
15. Katz SD & Krum H 2001 Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor. American Journal of Cardiology 87 1089-1092.
16. Lüscher TF & Vanhoutte PM 1990 The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press.
17. Martínez MC, Vila JM, Aldasoro M, Medina P, Chuan P & Lluch S 1994 The human deferential artery: endothelium-mediated contraction in response to adrenergic stimulation. European Journal of Pharmacology 261 73-78.
18. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H & Takeshita A 2000 Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. Journal of Clinical Investigation 106 1521-1530.
19. Matoba T, Shimokawa H, Kutota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y & Takeshita A 2002 Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochemical and Biophysical Research Communications 290 909-913.
20. Medina P, Noguera I, Aldasoro M, Vila JM, Flor B & Lluch S 1997 Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. American Journal of Physiology 272 H1087-H1093.
21. Millatt LJ, Johnstone AP, Nussey SS & Whitley GS 2000 Thyrocyte release of asymmetric dimethylarginine does not account for human thyrocyte inhibition of endothelial cell cyclic GMP. European Journal of Endocrinology 142 493-499.
22. + channels. Circulation 99 3132-3138.
23. Palmer RMJ, Ashton DS & Moncada S 1988 Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333 664-666.
24. Petersson J, Zygmunt PM & Hogestatt ED 1997 Characterization of the potassium channels involved in EDHF-mediated relaxations in cerebral arteries. British Journal of Pharmacology 120 1344-1350.
25. Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI & Kendall DA 1996 An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochemical and Biophysical Research Communications 229 114-120.
26. Rees DD, Palmer RMJ, Hodson HF & Moncada S 1989 A specific inhibitor of nitric oxide formation front L-arginine attenuates endothelium-dependent relaxation. British Journal of Pharmacology 96 418-424.
27. Rees DD, Palmer RMJ, Schulz R, Hodson HF & Moncada S 1990 Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology 101 746-752.
28. Scotland RS, Chauhan S, Vallance PJ & Ahluwalia A 2001 An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide. Hypertension 38 833-839.
29. Segarra G, Medina P, Acuña A, Domenech C, Martínez-León JB, Vila JM & Lluch S 1999 Comparative effects of dilator drugs on human penile dorsal artery and deep dorsal vein. Clinical Science 96 59-65.
30. Segarra, G, Medina, P, Vila, JM, Martínez-León, JB, Ballester, RM, Lluch, P & Lluch, S 2000 Contractile effects of arginine analogues on human internal thoracic and radial arteries. Journal of Thoracic and Cardiovascular Surgery 120 729-736.
31. Segarra G, Medina P, Vila JM, Chuan P, Domenech C & Lluch S 2002 Increased contraction to noradrenaline by vasopressin in human renal arteries. Journal of Hypertension 20 1373-1379.
32. Shimokawa H & Takeshita A 1995 Endothelium-dependent regulation of the cardiovascular system. Internal Medicine 34 939-946.
33. Suzuki H & Cheng G 1990 Endothelium-derived hyperpolarizing factor (EDHF): an endogenous potassium-channel activator. News in Physiological Sciences 5 212-215.
34. Taylor SG & Weston AH 1988 Endothelium-derived hyperpolarising factor: a new endogenous inhibitor from the vascular endothelium. Trends in Pharmacological Sciences 9 272-274.
35. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K & Takeshita A 1997 Importance of endothelium-derived hyperpolarizing factor in human arteries. Journal of Clinical Investigation 100 2793-2799.
36. Vallance P, Collier J & Moncada S 1989 Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2 997-1000.
37. Vanhoutte PM 1996 Endothelium-Derived Hyperpolarizing Factor. Amsterdam: Harwood Academic Publishers.
38. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y & Kajiya F 2003 Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107 1040-1045.
39. Zygmunt PM 1996 Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. British Journal of Pharmacology 117 1600-1606.
40. Zygmunt PM, Edwards AH, Weston AH, Larsson B & Högestätt ED 1997 Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery. British Journal of Clinical Pharmacology 121 141-149.